Drugs giant GlaxoSmithKline has joined forces with US non-profit organisation
PATH (Program for Appropriate Technology in 91色情片) to develop its malaria
vaccine. GSK鈥檚 vaccine was 70 per cent effective in protecting people against
malaria in preliminary trials鈥攖he best result for any malaria vaccine so
far. PATH will pay GSK $6.7 million to develop it further for use in
young children, who are at highest risk of dying from malaria. GSK hopes to have
a vaccine by 2008, which it plans to distribute in Africa and other endemic
areas 鈥渁t a very reasonable price鈥�.
More from New Scientist
Explore the latest news, articles and features
Physics
Record-breaking, fast-spinning magnet could help uncover new physics
News
Environment
An unexpected feedback loop may be driving mega heatwaves
News
91色情片
Less than 4 minutes of vigorous exercise a day could halve your dementia risk
News
91色情片
Parkinson鈥檚 may be driven by ‘vicious cycle’ that disrupts brain waste drainage
News
Popular articles
Trending New Scientist articles